Top 10 Books about Stock Investing to read in 2018. Read more.

VKTX - Viking Therapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

VKTX - Viking Therapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Fri 16'th Feb 2018

PERIOD 2017-11-17 - 2018-02-16
CHANGE -0.80%
PRICE $6.18






Viking Therapeutics Stock Analysis

Technical stock analysis for Fri 16'th Feb 2018

Shorts 1.75% ( 2018-01-31 )
Cash 47.4 mill
Loans 7.0 mill
Beta 1.93
ROA -139.45
Buy candidate since 2018-01-17 Gain 41.10%

Viking Therapeutics fell by -0.80% in the last day from $6.23 to $6.18 The price has been going up and down for this period, and there has been a 1.81% gain for the last 2 weeks. Volume has increased in the last day by 1.09 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 2.32 million shares bought and sold for approximately $14.33 million.

Access today's Top 5 Buy Candidates


Viking Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 100.98% during the next 3 months and, with 90% probability hold a price between $11.23 and $14.78 at the end of this period.

Click here for today's Top 5 Trending Companies


Viking Therapeutics holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $6.22. On a fall, the stock will find some support from the long-term average at approximately $5.31. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Tuesday February 13, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 56 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Viking Therapeutics finds support from accumulated volume at $6.07. On the upside the stock meets some resistance just above today's level from accumulated volume at $6.33, $6.35 and $6.93.

The stock is about to test the resistance from accumulated volume at $6.33 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $6.07 Price: $6.18 Resistance: $6.33


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.59 between high and low, or 9.59%. For the last week, the stock has had a daily average volatility of 7.84%.

Our recommended stoploss: $5.76 (-6.79%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 3 days ago.)

Overall risk:

Very Low Low Medium High Very High

Trade VKTX CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).